Article Per Year (5 Year)
p-Index From 2019 - 2024
2.859
P-Index
This Author published in this journals
All Journal Jurnal Pengabdian Kepada Masyarakat (Indonesian Journal of Community Engagement) Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Majalah Farmasi dan Farmakologi (Trends in Pharmacy and Pharmaceutical Sciences) Jurnal Farmasi Indonesia Gemakes: Jurnal Pengabdian Kepada Masyarakat Prosiding SIMKESNAS Acta Holistica Pharmaciana Parapemikir Jurnal Ilmiah Farmasi
Putu Dian Marani Kurnianta
Sekolah Tinggi Farmasi Mahaganesha
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Decision Sciences, Operations Research & Management Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Physics Public Health Other

Published : 14 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Jurnal Farmasi Indonesia

 1 
Evaluasi Rasionalitas Penggunaan Antidiabetes Oral pada Pasien Diabetes Melitus Tipe 2 Rawat Inap di Rumah Sakit Nasional di Dili Putu Dian Marani Kurnianta; Gracia Isabel Baptista Soares; Anak Agung Ngurah Putra Riana Prasetya; Agustina Nila Yuliawati
Jurnal Farmasi Indonesia Vol 19 No 1 (2022): Jurnal Farmasi Indonesia
Publisher : Fakultas Farmasi Universitas Setia Budi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31001/jfi.v19i1.1338

Abstract

Among several types of diabetes mellitus (DM), type-2 DM seemed to demonstrate the highest prevalence. Appropriate management in type-2 DM should follow rational use of antidiabetic agents to prevent any unfavorable impacts. In fact, due to the limited guidelines and medication resources, medication process for patients with type-2 DM has not been evaluated in Timor-Leste, especially at a national hospital in Dili. This was the first study which aimed to evaluate the use of oral antidiabetic agents (OAD) in hospitalized patients with type-2 DM at a national hospital, Dili Timor-Leste.This study was conducted retrospectively under cross-sectional design to describe the rational drug use evaluation based on indicators: right patient, right dose, right indication, right drug, and cautious to adverse events according to guideline from American Diabetes Association (2020). The included patients were diagnosed as type-2 DM, hospitalized during year 2020, and received OAD. Data were calculated (%) for each indicator of rational drug use.A total number of 83 hospitalized patients with type-2 DM at a national hospital in Dili had taken metformin (62.65%), gliclazide (12.15%), and combination of both metformin and gliclazide (22.89%), respectively. The evaluation results of OAD use according to ADA guideline comprised of right indication 100%, right patient 100%, right drug 72.28%, right dose 100%, and cautious to adverse events 93.7%. Despite favorable results in rational medication, enhancement for limitation of OAD use at a national hospital in Dili, Timor-Leste is compulsory.
Co-Authors Agustina Nila Yuliawati Anak Agung Ngurah Putra Riana Prasetya Astari, Ni Komang Eni Elisabeth Oriana Jawa La Elisabeth Oriana Jawa La Gede Agus Darmawan Gracia Isabel Baptista Soares Heny Dwi Arini I Gede Komang Aditya Pramana I Gede Krisna Yudiarta I Gusti Ayu Indira Ardeliani I Gusti Ayu Putu Prima Purnamasari I Komang Tri Musthika I Made Harry Prawira Nugraha I Made Ngurah Arya Kresna Acharya Putra I Putu Gede Hendra Wiarta Kadek Duwi Cahyadi Kadek Ria Dwitya Putra Ketut Tia Pran Anggar Yani Luh Gede Tina Sujayanti Mahadri Dhrik Mahadri Dhrik Ni Kadek Ayu Sri Darma Putri Ni Ketut Esati Ni Komang Ari Darmiati Ni Luh Putu Asra Dianita Ni Made Ayu Lestari Ni Putu Arik Candra Wahyuni Ni Putu Diah Wulandari Ni Putu Sudiasih Orpa Massode Pande Made Desy Ratnasari Pande Made Desy Ratnasari Powen Ester Jacqlien Fangidae Powen Ester Jacqlien Fangidae Prasetya, Anak Agung Ngurah Putra Riana Repining Tiyas Sawiji Ricardo, I Komang Aan Adi